Centre Hospitalier et Universitaire de Nantes, Hématologie Clinique, Nantes, France.
Hematology Am Soc Hematol Educ Program. 2010;2010:229-36. doi: 10.1182/asheducation-2010.1.229.
Allogeneic bone marrow transplantation (allo-BMT) or stem cell transplantation has the potential to cure a significant proportion of patients with otherwise fatal diseases. At present, immediate survival is no longer the sole concern after allo-BMT, because many patients can survive the acute complications of the procedure and remain free of their original disease for several years. Although long-term allo-BMT survivors generally enjoy good health, for many others cure or control of the underlying disease is not accompanied by full restoration of health. The long-term physiologic effects after allo-BMT include nonmalignant organ or tissue dysfunction; changes in quality of life; infections related to delayed, or abnormal, immune reconstitution; and secondary cancers. These long-term complications and the features of chronic graft-versus-host disease (GVHD) symptoms are heterogeneous in nature, time of onset, duration, and severity. The underlying origin of these complications is often multifactorial, with chronic GVHD being the most challenging risk factor. The main aims of this review are to present transplant physicians and health care providers with an overview of these malignant and nonmalignant late complications, with a special focus on chronic GVHD. A close partnership between the transplant center, organ-specific specialties, and local primary care providers is a key component of preventive medicine. The patient can play a major role through engagement in health maintenance behaviors.
异基因骨髓移植(allo-BMT)或干细胞移植有可能治愈很大一部分 otherwise fatal diseases 的患者。目前,allo-BMT 后立即存活已不再是唯一关注的问题,因为许多患者可以在手术的急性并发症后存活下来,并在数年中保持无原发病。尽管 allo-BMT 的长期幸存者通常身体健康,但对许多其他人来说,疾病的治愈或控制并不伴随着健康的完全恢复。allo-BMT 后的长期生理影响包括非恶性器官或组织功能障碍;生活质量的变化;与延迟或异常免疫重建相关的感染;以及继发性癌症。这些长期并发症和慢性移植物抗宿主病(GVHD)症状的特征在性质、发病时间、持续时间和严重程度上具有异质性。这些并发症的根本原因往往是多因素的,慢性 GVHD 是最具挑战性的危险因素。本综述的主要目的是向移植医生和医疗保健提供者介绍这些恶性和非恶性晚期并发症的概述,特别关注慢性 GVHD。移植中心、器官特异性专业和当地初级保健提供者之间的密切合作是预防医学的关键组成部分。患者可以通过参与健康维护行为发挥重要作用。